Zhejiang Yatai Pharmaceutical Co Ltd
SZSE:002370
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Zhejiang Yatai Pharmaceutical Co Ltd
Accounts Payable
Zhejiang Yatai Pharmaceutical Co Ltd
Accounts Payable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Zhejiang Yatai Pharmaceutical Co Ltd
SZSE:002370
|
Accounts Payable
¥50m
|
CAGR 3-Years
0%
|
CAGR 5-Years
16%
|
CAGR 10-Years
4%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Accounts Payable
¥334.3m
|
CAGR 3-Years
15%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Accounts Payable
¥2.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
20%
|
CAGR 10-Years
15%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Accounts Payable
¥7.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
10%
|
CAGR 10-Years
12%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Accounts Payable
¥1.9B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
11%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Accounts Payable
¥498m
|
CAGR 3-Years
90%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
|
Zhejiang Yatai Pharmaceutical Co Ltd
Glance View
Zhejiang Yatai Pharmaceutical Co., Ltd. engages in the research, manufacture & distribution of drugs. The company is headquartered in Shaoxing, Zhejiang and currently employs 584 full-time employees. The company went IPO on 2010-03-16. The firm's main business consists of the research, development, production and sales of chemical agents, chemical raw materials and diagnostic reagents, as well as the provision of pharmaceutical research and development outsourcing (CRO) services. The Company’s chemical agents are classified as antibiotics and non-antibiotic drugs. Along with its subsidiaries, the Company provides preclinical research services, clinical research services and other advisory services. The firm distributes its products primarily in domestic markets and overseas markets.
See Also
What is Zhejiang Yatai Pharmaceutical Co Ltd's Accounts Payable?
Accounts Payable
50m
CNY
Based on the financial report for Sep 30, 2025, Zhejiang Yatai Pharmaceutical Co Ltd's Accounts Payable amounts to 50m CNY.
What is Zhejiang Yatai Pharmaceutical Co Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
4%
Over the last year, the Accounts Payable growth was 43%.
